FR2987265B1 - Composition pharmaceutique sous forme de sirop a base de modafinil, son procede de fabrication et son application - Google Patents
Composition pharmaceutique sous forme de sirop a base de modafinil, son procede de fabrication et son applicationInfo
- Publication number
- FR2987265B1 FR2987265B1 FR1200579A FR1200579A FR2987265B1 FR 2987265 B1 FR2987265 B1 FR 2987265B1 FR 1200579 A FR1200579 A FR 1200579A FR 1200579 A FR1200579 A FR 1200579A FR 2987265 B1 FR2987265 B1 FR 2987265B1
- Authority
- FR
- France
- Prior art keywords
- modafinil
- producing
- application
- pharmaceutical composition
- same
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Neurosurgery (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Inorganic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR1200579A FR2987265B1 (fr) | 2012-02-28 | 2012-02-28 | Composition pharmaceutique sous forme de sirop a base de modafinil, son procede de fabrication et son application |
PCT/FR2013/000050 WO2013128086A1 (fr) | 2012-02-28 | 2013-02-25 | Composition pharmaceutique sous forme de sirop à base de modafinil, son procédé de fabrication et son application |
TW102106510A TW201340994A (zh) | 2012-02-28 | 2013-02-25 | 呈現莫達非尼糖漿之藥物組成物、其製造方法及其應用 |
ARP130100594A AR090167A1 (es) | 2012-02-28 | 2013-02-27 | Composicion farmaceutica cuyo principio activo es el modafinilo en su forma de enantiomero s presentandose como un jarabe |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR1200579A FR2987265B1 (fr) | 2012-02-28 | 2012-02-28 | Composition pharmaceutique sous forme de sirop a base de modafinil, son procede de fabrication et son application |
Publications (2)
Publication Number | Publication Date |
---|---|
FR2987265A1 FR2987265A1 (fr) | 2013-08-30 |
FR2987265B1 true FR2987265B1 (fr) | 2014-02-28 |
Family
ID=48083445
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FR1200579A Expired - Fee Related FR2987265B1 (fr) | 2012-02-28 | 2012-02-28 | Composition pharmaceutique sous forme de sirop a base de modafinil, son procede de fabrication et son application |
Country Status (4)
Country | Link |
---|---|
AR (1) | AR090167A1 (fr) |
FR (1) | FR2987265B1 (fr) |
TW (1) | TW201340994A (fr) |
WO (1) | WO2013128086A1 (fr) |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5618845A (en) * | 1994-10-06 | 1997-04-08 | Cephalon, Inc. | Acetamide derivative having defined particle size |
KR100911952B1 (ko) * | 2000-10-11 | 2009-08-13 | 세파론, 인코포레이티드 | 모다피닐 화합물을 포함하는 조성물 |
US6919378B2 (en) | 2000-10-11 | 2005-07-19 | Cephalon, Inc. | Pharmaceutical solutions of modafinil compounds |
US6489363B2 (en) | 2000-10-11 | 2002-12-03 | Cephalon, Inc. | Pharmaceutical solutions of modafinil compounds |
US7576133B2 (en) | 2002-03-11 | 2009-08-18 | Carl Henry Lawyer | Methods and compositions for nasal administration of modafinil |
US20040116532A1 (en) * | 2002-09-13 | 2004-06-17 | Craig Heacock | Pharmaceutical formulations of modafinil |
US20050008704A1 (en) | 2003-07-11 | 2005-01-13 | Ray Anup Kumar | Pharmaceutical composition for solubility enhancement of hydrophobic drugs |
US20060024370A1 (en) * | 2004-07-29 | 2006-02-02 | Cephalon France | Modafinil oral lyophilizate |
EP1891938A1 (fr) * | 2006-07-24 | 2008-02-27 | Cephalon France | Haute dose soluble oralement d'une forme de dosage lyophilisé. |
US8173169B2 (en) * | 2007-07-11 | 2012-05-08 | Hikma Pharmaceuticals | Formulation and process for the preparation of modafinil |
-
2012
- 2012-02-28 FR FR1200579A patent/FR2987265B1/fr not_active Expired - Fee Related
-
2013
- 2013-02-25 TW TW102106510A patent/TW201340994A/zh unknown
- 2013-02-25 WO PCT/FR2013/000050 patent/WO2013128086A1/fr active Application Filing
- 2013-02-27 AR ARP130100594A patent/AR090167A1/es unknown
Also Published As
Publication number | Publication date |
---|---|
WO2013128086A1 (fr) | 2013-09-06 |
TW201340994A (zh) | 2013-10-16 |
FR2987265A1 (fr) | 2013-08-30 |
AR090167A1 (es) | 2014-10-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR112013030472A2 (pt) | formulação farmacêutica, artigo de fabricação e método | |
BR112013033811A2 (pt) | composição, método de preparação da composição, e, composto | |
BR112013031916A2 (pt) | composição nucicional,uso de uma composição nutricional, processo para a fabricação de uma composição nutricional, e produto | |
BR112014010391A2 (pt) | composto, composição farmacêutica, processo de produção de uma composição farmacêutica, método de tratamento, kit e uso de uma composição farmacêutica | |
FR2991320B1 (fr) | Procede de preparation d'amines methylees | |
BR112014010460A2 (pt) | composto, composição farmacêutica, processo para produzir uma composição farmacêutica, método de tratamento, kit e uso de uma composição farmacêutica | |
BR112013007276A2 (pt) | composição farmacêutica, processo para preparar uma composição farmacêutica, uso da coposição farmacêutica e método para tratar sobrecarga crônica de ferro | |
SG11201408156PA (en) | Mold base material, production method for mold base material, mold production method, and mold | |
BR112012026843A2 (pt) | composição, composição farmacêutica, processo para preparar uma composição farmacêutica, uso de uma composição e método para tratamento de hiv | |
BR112014020603A2 (pt) | composição formadora de gel, unidade de envidraçamento, processo para formar uma unidade de envidraçamento, e, método para fabricar uma composição formadora de gel | |
PL2770827T3 (pl) | Kompozycja, sposób otrzymywania kompozycji i zawierająca ją formulacja fitosanitarna | |
EP2851421A4 (fr) | Microorganisme utile, et procédé de production d'une substance souhaitée | |
CO6862129A2 (es) | Aparato y proceso para la producción de un producto de células encapsuladas | |
BR112012021066A2 (pt) | processo de preparação de uma composição, composição e aplicação da composição | |
BR112014026565A2 (pt) | formulação, uso de uma formulação, e, processo para produzir uma formulação | |
BR112015026371A2 (pt) | composição para a preparação de bactéria probiótica, produto alimentar líquido, processo para a preparação de bactéria probiótica, e processo para a preparação de um produto alimentar com base líquida | |
FR2985734B1 (fr) | Composition de biocombustible et procede de fabrication d'un biocombustible | |
BR112013022930A2 (pt) | composição farmacêutica, uso de uma composição farmacêutica, e, processo para produzir uma composição farmacêutica | |
BR112014025972A2 (pt) | monocloridrato de anamorelina, composição, processo para preparar monocloridrato de anamorelina, composição farmacêutica e método para produzir uma forma de dosagem farmacêutica | |
BR112012025490A2 (pt) | ''método para produção de 1,5 oebtanodiamina'' | |
EP2742946A4 (fr) | Procédé pour la production de dérivés de pyrostegia venusta, dérivés de pyrostegia venusta, compositions pharmaceutiques et leurs utilisations | |
BR112013015501A2 (pt) | composto, composição farmacêutica, métodos para tratamento de infecções virais e de distúrbios inflamatórios, e, processo para produzir uma sangliferrina mutassintética | |
FR2994634B1 (fr) | Composition alimentaire a base de spiruline fraiche et procede de preparation | |
BR112013013415A2 (pt) | composição farmacêutica, e, método para a preparação de uma composição | |
BR112014011745A2 (pt) | composição farmacêutica, e, processo para a fabricação de uma composição farmacêutica de hidrocortisona |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PLFP | Fee payment |
Year of fee payment: 5 |
|
PLFP | Fee payment |
Year of fee payment: 6 |
|
PLFP | Fee payment |
Year of fee payment: 7 |
|
PLFP | Fee payment |
Year of fee payment: 8 |
|
ST | Notification of lapse |
Effective date: 20201005 |